HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS - US4330001060 - Common Stock
44.57 USD
+0.61 (+1.39%)
44.7296 USD
+0.16 (+0.36%)
Overall HIMS gets a fundamental rating of 6 out of 10. We evaluated HIMS against 101 industry peers in the Health Care Providers & Services industry. HIMS has an average financial health and profitability rating. HIMS shows excellent growth, but is valued quite expensive already. This makes HIMS very considerable for growth investing!
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
HIMS had a positive operating cash flow in the past year.
In the past 5 years HIMS reported 4 times negative net income.
In multiple years HIMS reported negative operating cash flow during the last 5 years.
1.2 Ratios
HIMS has a Return On Assets of 10.31%. This is amongst the best in the industry. HIMS outperforms 95.19% of its industry peers.
HIMS has a Return On Equity of 34.41%. This is amongst the best in the industry. HIMS outperforms 96.15% of its industry peers.
HIMS's Return On Invested Capital of 6.74% is fine compared to the rest of the industry. HIMS outperforms 68.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROIC | 6.74% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a better Profit Margin (9.62%) than 93.27% of its industry peers.
Looking at the Operating Margin, with a value of 6.80%, HIMS is in the better half of the industry, outperforming 67.31% of the companies in the same industry.
Looking at the Gross Margin, with a value of 76.20%, HIMS belongs to the top of the industry, outperforming 89.42% of the companies in the same industry.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HIMS is destroying value.
HIMS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HIMS has more shares outstanding
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 6.49 indicates that HIMS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.49, HIMS belongs to the top of the industry, outperforming 89.42% of the companies in the same industry.
HIMS has a debt to FCF ratio of 8.11. This is a slightly negative value and a sign of low solvency as HIMS would need 8.11 years to pay back of all of its debts.
HIMS has a better Debt to FCF ratio (8.11) than 60.58% of its industry peers.
HIMS has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of HIMS (1.72) is worse than 71.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Altman-Z | 6.49 |
ROIC/WACC0.76
WACC8.9%
2.3 Liquidity
A Current Ratio of 4.98 indicates that HIMS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.98, HIMS belongs to the top of the industry, outperforming 93.27% of the companies in the same industry.
HIMS has a Quick Ratio of 4.46. This indicates that HIMS is financially healthy and has no problem in meeting its short term obligations.
HIMS has a Quick ratio of 4.46. This is amongst the best in the industry. HIMS outperforms 93.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 900.00% over the past year.
The Earnings Per Share has been growing by 60.35% on average over the past years. This is a very strong growth
Looking at the last year, HIMS shows a very strong growth in Revenue. The Revenue has grown by 88.69%.
The Revenue has been growing by 75.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%183.33%
Revenue 1Y (TTM)88.69%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%72.61%
3.2 Future
Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 41.75% on average per year.
HIMS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.12% yearly.
EPS Next Y11.07%
EPS Next 2Y23.28%
EPS Next 3Y24.28%
EPS Next 5Y41.75%
Revenue Next Year59.8%
Revenue Next 2Y38.12%
Revenue Next 3Y31.12%
Revenue Next 5Y21.12%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 55.71, which means the current valuation is very expensive for HIMS.
The rest of the industry has a similar Price/Earnings ratio as HIMS.
Compared to an average S&P500 Price/Earnings ratio of 27.24, HIMS is valued quite expensively.
HIMS is valuated quite expensively with a Price/Forward Earnings ratio of 54.31.
HIMS's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of HIMS to the average of the S&P500 Index (22.81), we can say HIMS is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.71 | ||
| Fwd PE | 54.31 |
4.2 Price Multiples
HIMS's Enterprise Value to EBITDA ratio is in line with the industry average.
HIMS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 84.29 | ||
| EV/EBITDA | 59.49 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HIMS may justify a higher PE ratio.
HIMS's earnings are expected to grow with 24.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.03
PEG (5Y)0.92
EPS Next 2Y23.28%
EPS Next 3Y24.28%
5. Dividend
5.1 Amount
No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
44.57
+0.61 (+1.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners81.86%
Inst Owner Change9.04%
Ins Owners10.73%
Ins Owner Change8.21%
Market Cap10.07B
Analysts70
Price Target51.38 (15.28%)
Short Float %33.88%
Short Ratio1.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.23%
Min EPS beat(2)10.29%
Max EPS beat(2)62.17%
EPS beat(4)4
Avg EPS beat(4)185.99%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)152.2%
EPS beat(12)11
Avg EPS beat(12)111.23%
EPS beat(16)12
Avg EPS beat(16)74.99%
Revenue beat(2)1
Avg Revenue beat(2)1.79%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)6.75%
Revenue beat(4)3
Avg Revenue beat(4)1.72%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.23%
Revenue beat(12)9
Avg Revenue beat(12)2.03%
Revenue beat(16)13
Avg Revenue beat(16)3.23%
PT rev (1m)4.38%
PT rev (3m)18.17%
EPS NQ rev (1m)-33.42%
EPS NQ rev (3m)-40.41%
EPS NY rev (1m)-11.98%
EPS NY rev (3m)-5.16%
Revenue NQ rev (1m)-0.71%
Revenue NQ rev (3m)1.3%
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.71 | ||
| Fwd PE | 54.31 | ||
| P/S | 5 | ||
| P/FCF | 84.29 | ||
| P/OCF | 38.5 | ||
| P/B | 17.9 | ||
| P/tB | 24.92 | ||
| EV/EBITDA | 59.49 |
EPS(TTM)0.8
EY1.79%
EPS(NY)0.82
Fwd EY1.84%
FCF(TTM)0.53
FCFY1.19%
OCF(TTM)1.16
OCFY2.6%
SpS8.91
BVpS2.49
TBVpS1.79
PEG (NY)5.03
PEG (5Y)0.92
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 23.47% | ||
| ROICexgc | 35.76% | ||
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% | ||
| FCFM | 5.94% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score6
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Debt/EBITDA | 5.84 | ||
| Cap/Depr | 486.96% | ||
| Cap/Sales | 7.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 157.56% | ||
| Profit Quality | 61.73% | ||
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 | ||
| Altman-Z | 6.49 |
F-Score6
WACC8.9%
ROIC/WACC0.76
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)900%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%183.33%
EPS Next Y11.07%
EPS Next 2Y23.28%
EPS Next 3Y24.28%
EPS Next 5Y41.75%
Revenue 1Y (TTM)88.69%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%72.61%
Revenue Next Year59.8%
Revenue Next 2Y38.12%
Revenue Next 3Y31.12%
Revenue Next 5Y21.12%
EBIT growth 1Y821.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year364.13%
EBIT Next 3Y97.59%
EBIT Next 5Y60.92%
FCF growth 1Y927.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y922.97%
OCF growth 3YN/A
OCF growth 5YN/A